Cargando…

Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus

BACKGROUND: The Lyon Consensus delineates impedance‐pH parameters that can demonstrate/exclude gastro‐oesophageal reflux disease (GERD). In patients with acid exposure time between 4% and 6%, GERD diagnosis has been considered inconclusive. In these cases, mean nocturnal baseline impedance (MNBI) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribolsi, Mentore, Frazzoni, Marzio, Marabotto, Elisa, De Carlo, Giovanni, Ziola, Sebastiano, Maniero, Daria, Balestrieri, Paola, Cicala, Michele, Savarino, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361916/
https://www.ncbi.nlm.nih.gov/pubmed/34181753
http://dx.doi.org/10.1111/apt.16481
_version_ 1783738044576169984
author Ribolsi, Mentore
Frazzoni, Marzio
Marabotto, Elisa
De Carlo, Giovanni
Ziola, Sebastiano
Maniero, Daria
Balestrieri, Paola
Cicala, Michele
Savarino, Edoardo
author_facet Ribolsi, Mentore
Frazzoni, Marzio
Marabotto, Elisa
De Carlo, Giovanni
Ziola, Sebastiano
Maniero, Daria
Balestrieri, Paola
Cicala, Michele
Savarino, Edoardo
author_sort Ribolsi, Mentore
collection PubMed
description BACKGROUND: The Lyon Consensus delineates impedance‐pH parameters that can demonstrate/exclude gastro‐oesophageal reflux disease (GERD). In patients with acid exposure time between 4% and 6%, GERD diagnosis has been considered inconclusive. In these cases, mean nocturnal baseline impedance (MNBI) and post‐reflux swallow‐induced peristaltic wave (PSPW) index may either confirm or refute GERD diagnosis and represent predictors of proton pump inhibitor (PPI) response. AIMS: To investigate the diagnostic yield of MNBI and PSPW index and their relationship with PPI response in patients with inconclusive GERD diagnosis. METHODS: Review of impedance‐pH tracings from PPI responder/non‐responder patients with typical reflux symptoms. Multivariate regression analysis was performed to determine the association of MNBI and PSPW index to PPI response. RESULTS: Among 233 patients evaluated, 145/233 (62.2%) were PPI responders; 62 had conclusive and 65 inconclusive evidence of GERD, 46 had reflux hypersensitivity, and 60 functional heartburn. Abnormal MNBI and PSPW index were significantly more frequent in inconclusive GERD as compared to the functional heartburn group (P < 0.001). Within the inconclusive GERD group, 35/65 (54%) patients were PPI responders and displayed a significantly higher proportion of cases with pathological MNBI or PSPW index as compared to non‐responders (32/35 [91.4%] and 30/35 [85.7%] vs 9/30 [30%] and 7/30 [23.3%], P < 0.001). By multivariate analysis, pathological PSPW index and/or MNBI values were significantly associated with PPI response in all groups. CONCLUSIONS: The present study highlights the value of MNBI and PSPW index as adjunctive metrics in characterising patients with inconclusive evidence of GERD and identifying those responsive to PPI treatment.
format Online
Article
Text
id pubmed-8361916
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83619162021-08-17 Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus Ribolsi, Mentore Frazzoni, Marzio Marabotto, Elisa De Carlo, Giovanni Ziola, Sebastiano Maniero, Daria Balestrieri, Paola Cicala, Michele Savarino, Edoardo Aliment Pharmacol Ther IMPEDANCE‐pH AND PPI RESPONSE IN GERD BACKGROUND: The Lyon Consensus delineates impedance‐pH parameters that can demonstrate/exclude gastro‐oesophageal reflux disease (GERD). In patients with acid exposure time between 4% and 6%, GERD diagnosis has been considered inconclusive. In these cases, mean nocturnal baseline impedance (MNBI) and post‐reflux swallow‐induced peristaltic wave (PSPW) index may either confirm or refute GERD diagnosis and represent predictors of proton pump inhibitor (PPI) response. AIMS: To investigate the diagnostic yield of MNBI and PSPW index and their relationship with PPI response in patients with inconclusive GERD diagnosis. METHODS: Review of impedance‐pH tracings from PPI responder/non‐responder patients with typical reflux symptoms. Multivariate regression analysis was performed to determine the association of MNBI and PSPW index to PPI response. RESULTS: Among 233 patients evaluated, 145/233 (62.2%) were PPI responders; 62 had conclusive and 65 inconclusive evidence of GERD, 46 had reflux hypersensitivity, and 60 functional heartburn. Abnormal MNBI and PSPW index were significantly more frequent in inconclusive GERD as compared to the functional heartburn group (P < 0.001). Within the inconclusive GERD group, 35/65 (54%) patients were PPI responders and displayed a significantly higher proportion of cases with pathological MNBI or PSPW index as compared to non‐responders (32/35 [91.4%] and 30/35 [85.7%] vs 9/30 [30%] and 7/30 [23.3%], P < 0.001). By multivariate analysis, pathological PSPW index and/or MNBI values were significantly associated with PPI response in all groups. CONCLUSIONS: The present study highlights the value of MNBI and PSPW index as adjunctive metrics in characterising patients with inconclusive evidence of GERD and identifying those responsive to PPI treatment. John Wiley and Sons Inc. 2021-06-28 2021-08 /pmc/articles/PMC8361916/ /pubmed/34181753 http://dx.doi.org/10.1111/apt.16481 Text en © 2021 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle IMPEDANCE‐pH AND PPI RESPONSE IN GERD
Ribolsi, Mentore
Frazzoni, Marzio
Marabotto, Elisa
De Carlo, Giovanni
Ziola, Sebastiano
Maniero, Daria
Balestrieri, Paola
Cicala, Michele
Savarino, Edoardo
Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
title Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
title_full Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
title_fullStr Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
title_full_unstemmed Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
title_short Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
title_sort novel impedance‐ph parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to lyon consensus
topic IMPEDANCE‐pH AND PPI RESPONSE IN GERD
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361916/
https://www.ncbi.nlm.nih.gov/pubmed/34181753
http://dx.doi.org/10.1111/apt.16481
work_keys_str_mv AT ribolsimentore novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT frazzonimarzio novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT marabottoelisa novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT decarlogiovanni novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT ziolasebastiano novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT manierodaria novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT balestrieripaola novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT cicalamichele novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus
AT savarinoedoardo novelimpedancephparametersareassociatedwithprotonpumpinhibitorresponseinpatientswithinconclusivediagnosisofgastrooesophagealrefluxdiseaseaccordingtolyonconsensus